US Patent 8524780 Deuterium-enriched bupropion
Patent 8524780 was granted and assigned to DeuteRx on September, 2013 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
May 19, 2010
Date of Patent
September 3, 2013
Patent Application Number
12783487
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 8524780 Deuterium-enriched bupropion
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.